PZLV - ETF AI Analysis
Top Page
Pzena U.S. Large Cap Value ETF (PZLV)
Rating:68Neutral
Price Target:―
Positive Factors
Strong Overall Performance
The ETF has shown strong gains so far this year and over recent months, indicating solid momentum.
Healthy Top Holdings Performance
Most of the largest positions, especially in health care and financials, have delivered strong returns, supporting the fund’s results.
Broad Sector Diversification
The fund spreads its investments across several sectors, which helps reduce the impact if one industry faces a downturn.
Negative Factors
Higher Expense Ratio
The ETF’s fee is on the higher side for a passive fund, which slightly reduces the net return investors keep over time.
U.S.-Only Geographic Focus
With almost all assets in U.S. companies, the fund offers little international diversification and is sensitive to U.S. market conditions.
Mixed Performance Among Top Holdings
A few major positions, such as Dollar General, Wells Fargo, and Capital One Financial, have shown weaker performance, which can drag on overall returns.
PZLV vs. SPDR S&P 500 ETF (SPY)
AUM68.61M
RegionNorth America
Expense Ratio0.60%
Beta0.41
IssuerPzena
Inception DateApr 01, 2026
Dividend YieldN/A
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume168
30 Day Avg. Volume1,144
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
34.74Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering39
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
PZLV Summary
Pzena U.S. Large Cap Value ETF (PZLV) is an actively managed fund that focuses on large, established U.S. companies that appear undervalued based on their earnings and financial strength. Instead of tracking a fixed index, professional managers pick stocks they believe are priced lower than they should be, aiming for long-term growth as values improve. The fund holds well-known names like Humana, CVS Health, Wells Fargo, and Capital One. Investors might consider it to tilt their portfolio toward value stocks and diversify across sectors. A key risk is that value stocks can stay out of favor for long periods, so performance can lag the broader market.
How much will it cost me?This ETF has an expense ratio of 0.60%, which means you’ll pay about $6 per year for every $1,000 invested. That’s higher than the average ETF because it’s actively managed, paying a professional team to research and pick value stocks rather than simply tracking an index.
What would affect this ETF?This ETF could benefit if the U.S. economy stays healthy, interest rates stabilize or fall, and investor sentiment shifts toward value stocks, which may help its large health care, financial, and technology holdings as well as companies like Baxter, Humana, and Wells Fargo. On the downside, higher interest rates, pressure on bank profits, changes to health care regulation, or a slowdown in consumer spending could hurt its financial and health care exposure and weigh on top holdings such as CVS, Capital One, and Dollar General.
PZLV Top 10 Holdings
PZLV is leaning hard into U.S. value, with a clear tilt toward health care and financials driving the story. Humana and Robert Half have been standout risers, giving the fund a solid tailwind, while Lear and Skyworks add some cyclical and tech flavor with generally rising but occasionally choppy performance. On the flip side, Baxter has been lagging and Capital One feels like it’s stuck in neutral, occasionally dragging on returns. Overall, this is a U.S.-only portfolio betting that beaten-down blue chips eventually get their comeback moment.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Humana | 5.12% | $3.53M | $47.78B | 52.66% | 69 Neutral | |
| Baxter International | 4.90% | $3.38M | $12.08B | 4.96% | 45 Neutral | |
| Corebridge Financial, Inc. | 4.69% | $3.23M | $15.54B | 2.21% | 67 Neutral | |
| Dollar General | 3.71% | $2.55M | $27.54B | 20.82% | 73 Outperform | |
| Lear | 3.54% | $2.44M | $6.05B | 20.12% | 75 Outperform | |
| Skyworks Solutions | 3.49% | $2.40M | $13.44B | 13.86% | 70 Outperform | |
| Metlife | 3.37% | $2.32M | $62.09B | 16.75% | 71 Outperform | |
| CVS Health | 3.26% | $2.24M | $113.99B | 16.25% | 64 Neutral | |
| Universal Health | 3.23% | $2.23M | $10.54B | -11.73% | 74 Outperform | |
| Fresenius Medical Care | 3.07% | $2.11M | $12.02B | -10.91% | 65 Neutral |
PZLV Technical Analysis
Negative
―
Price Trends
30.92
Negative
29.56
Positive
Market Momentum
-0.27
Positive
33.98
Neutral
2.48
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For PZLV, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 30.84, equal to the 50-day MA of 30.92, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of -0.27 indicates Positive momentum. The RSI at 33.98 is Neutral, neither overbought nor oversold. The STOCH value of 2.48 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for PZLV.
PZLV Peer Comparison
Comparison Results
Performance Comparison
PZLV
Pzena U.S. Large Cap Value ETF
29.84
4.77
19.03%
MAVF
Matrix Advisors Value ETF
―
―
―
PRXV
Praxis Impact Large Cap Value ETF
―
―
―
NSIV
North Square Disciplined Value ETF
―
―
―
DHLX
Diamond Hill Large Cap Concentrated ETF
―
―
―
DVAL
BrandywineGLOBAL - Dynamic US Large Cap Value ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents